Current clinical trials and surveys
Novel clinical research conducted by the Lambert Initiative’s clinical team and collaborators within Australia
Our clinical team, in collaboration with expert clinicians and researchers around Australia, are focused on developing clinical evidence for cannabinoid-based therapeutics and understanding Australian community use of medicinal cannabis in a range of disease areas.
Clinical Trials
The CANSLEEP Study
Exploring the effects of combined CBD and THC (20:1) on sleep and brain activation in patients with insomnia disorder. Eligible participants undergo two overnight sleep studies receiving randomised active and placebo treatments. This study is being led by Professor Ron Grunstein. See here for more information.
Study site: Woolcock Institute of Medical Research, Glebe, NSW 2037
Status: Recruiting
Exploring the effect of combined THC and CBD (1:1) on tics in patients with Tourette syndrome. Eligible participants will undergo two 8-week treatment periods receiving either active or placebo treatment. This study is being led by Dr Philip Mosley. See here for more information.
Study site: The Wesley Hospital, Coronation Dr, Auchenflower, QLD 4066
Status: Recruiting
Surveys
There are no currently active surveys.
Register here to be informed of upcoming surveys and trials.
See here for a list of past completed surveys.
Related articles
